Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).
|02/19/13||SC 13G||Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions||10|
|01/28/13||8-K||Current report filing||51|
|01/25/13||S-1||General form of registration statement for all companies including face-amount certificate companies||127|
|01/14/13||3||Saks Samuel R||2|
|01/14/13||8-A12G||Form for registration of a class of securities pursuant to section 12(g)||3|
|01/14/13||3||Mather Charles E Iv||2|
|01/14/13||3||Landry Donald W||2|